SCHEMBL9537396

SCHEMBL9537396

Fc1ccc(Cn2c(CC3CCN(CCNc4nc5cnccc5[nH]4)CC3)nc3cccnc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.48
TP53 P04637 7/20 0.43
POLB P06746 2/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 2/20 0.39
THRB P10828 1/20 0.39
RXFP1 Q9HBX9 2/20 0.39
ENPP2 Q13822 6/20 0.39
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9535432 0.93 TP53 (0.40) SLC6A9TP53POLBMAPTLMNA
SCHEMBL10549563 0.92 SLC6A9 (0.50) SLC6A9TP53POLBMAPTLMNA
SCHEMBL9539506 0.89 SSTR5 (0.44) TP53MAPTLMNATSHR
SCHEMBL10803216 0.88 SLC6A9 (0.40) SLC6A9TP53MAPTENPP2TSHR
SCHEMBL9537795 0.88 TSHR (0.41) SLC6A9TP53MAPTENPP2TSHR
SCHEMBL9536927 0.86 SLC6A9 (0.56) SLC6A9TP53POLBMAPTENPP2
SCHEMBL9536208 0.86 SLC6A9 (0.41) SLC6A9TP53POLBMAPTLMNA
SCHEMBL9535415 0.84 SLC6A9 (0.55) SLC6A9TP53POLBMAPTLMNA
SCHEMBL9536111 0.84 SLC6A9 (0.44) SLC6A9LMNATSHR
SCHEMBL9536096 0.83 MEN1 (0.46) MAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0151826-B1 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines JANSSEN PHARMACEUTICA N.V. (BE) 1993-03-31 EP disclosed
US-4839374-A TREATING ALLERGIES JANSSEN PHARMACEUTICA, N.V. (BE) 1989-06-13 US disclosed
US-4695575-A ANTIHISTAMINES JANSSEN PHARMACEUTICA, N.V. (BE) 1987-09-22 US disclosed
EP-0151826-A1 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines JANSSEN PHARMACEUTICA N.V. (BE) 1985-08-21 EP disclosed